Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA [Phase 3]

View source ↗

Summary

A Phase 3 trial is being planned to compare Enarodustat plus cyclosporine against cyclosporine alone in newly diagnosed transfusion-dependent non-severe aplasti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporine A (cyclosporine)
  • Enarodustat (enarodustat)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Transfusion-dependent Non-severe Aplastic Anemia | Phase 3 | Status: NOT_YET_RECRUITING